Mark Power, Ohad Goldberg, Gali Halperin, Efrat Morag and Arik Jonahag, Swedish Ambassador to Israel (PR photo)
Just before Passover, a final event of the second cycle of the PlayBeyondBio project in the field of digital health took place, which is jointly led by the British-Swedish pharma giant, Astraznica, the JVP venture capital fund, the international consulting giant Accenture, Margalit Startup City, Amazon Web Services and the Medical Center Justice in Jerusalem.
In the vision of the program; Support for Israeli innovation in the field of digital health in order to address the significant challenges faced by the global health system, through the application of digital technologies and their arrival in the patient and the health system, in Israel and around the world.
The six-month program featured eight startups selected from 100 candidates, who were individually mentored by program partners, promoting collaborations with international bodies, and forming connections with leading players in the global health systems. In the corporate elections, emphasis was placed on companies in the mature and advanced stages to enable the implementation of the technologies they have developed in the near term.
PlayBeyondBio combines Evidence Based Medicine with innovative science and technology, with the goal of bringing solutions in the shortest possible time to two target audiences: physicians and patients. Unlike other programs – the program focuses on promoting “digital health” in the practical and applied aspect by creating collaborations between start-ups and international pharma companies, investors, health institutions and international high-tech leaders including: Astraznica, JVP Foundation, international consulting giant Accenture, Margalit start-up City Community, Amazon Web Services and Shaare Zedek Medical Center.
During the second cycle of the program, the companies formed relationships with senior Astraznica executives towards the implementation of their technologies jointly in Europe, the US, Canada and Israel, were strategically accompanied by the product and market penetration by JVP, and worked with Accenture and AWS to ensure Their technological infrastructure is ready to scale up on a global scale and in accordance with different health systems.
Erel Margalit, Founder and Chairman of JVP and Margalit Startup City: “The global healthcare system has changed, and it faces in the post-Corona era, new big challenges that require groundbreaking technological developments. The world’s big problem is becoming a huge opportunity for Israeli high-tech. “Israel has a significant technological infrastructure and a broad ecosystem that enable it to become a world leader in digital health and bring to the world the next major initiatives that change the way medicine can be accessible to anyone, anywhere, anytime.”
Ohad Goldberg, CEO of AstraZenica Israel: “AstraZenica is proud to be a leading company in the development of life-saving drugs for some of the most difficult and complicated diseases today. It is important to us that Israel takes a significant part in the company’s ability to bring to the market also advanced technological solutions that will be integrated into drug treatment and provide greater added value to patients, doctors and the health system. In Israel, there are unique capabilities such as databases, advanced hospitals, AI development, etc. that can move this effort forward. PlayBeyondBio’s operations are part of a broader strategic vision and we are constantly exploring additional options for investing in the local ecosystem. Astraznika sees the importance of investing in start-up companies in Israel and is proud to lead this venture. ”
Shimon Alkabetz, CEO of Accenture Israel: The start-ups selected to take part in the PlayBeyondBio program were accepted after a rigorous and thorough selection process that saw before its eyes the need for the hour and the opportunities inherent in medicine in the coming decade. It is doubtful that this leading team faithfully represents the best prominent trends in the worlds of mid-tech and wellness, including the implementation of artificial intelligence applications and advanced processing of big data to streamline the decision-making process. Accenture is proud to support these brilliant teams. And expand their solutions. “
More in-
Prof. Dan Turner, VP of R&D, Shaare Zedek Medical Center: “When it comes to developing technologies in digital health, medical data and biological samples are the infrastructure for new products. We at Shaare Zedek can not only provide information and samples safely, but also provide the Clinical knowledge to make this data relevant and meaningful for healthcare product development companies.In Shaare Zedek’s giant servers, data from hundreds of thousands of medical files are documented each year, and our role in the technology development process is to promote access to medical staff data, samples and knowledge while fully maintaining “Privacy of personal information. We promote collaborations to test the products in a real clinical environment.”
Comments on the article(0):
Your response has been received and will be published subject to system policies.
Thanks.
For a new response
Your response was not sent due to a communication problem, please try again.
Return to comment